跳转至内容
Merck
CN

RAB0731

人KIT / Mast/干细胞生长因子受体ELISA试剂盒

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

NACRES:
NA.84
UNSPSC Code:
41116158
Gene information:
human ... KIT(3815)
Input:
sample type plasma
sample type serum
sample type cell culture supernatant(s)
Species reactivity:
human
Storage temp.:
−20°C
Shipped in:
wet ice
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


species reactivity

human

packaging

kit of 96 wells (12 strips x 8 wells)

technique(s)

ELISA: suitable

input

sample type plasma
sample type serum
sample type cell culture supernatant(s)

assay range

inter-assay cv: <12%
intra-assay cv: <10%
sensitivity: 45 pg/mL
standard curve range: 40.96-10000 pg/mL

detection method

colorimetric

shipped in

wet ice

storage temp.

−20°C

Gene Information

human ... KIT(3815)

General description

The antibody pair provided in this kit recognizes human Mast/Stem Cell Growth Factor Receptor Kit.

Application

请参考Protocol了解详情。


试剂盒组分也可单独购买

产品编号
说明
化学品安全说明书 & 价格

  • ELISA Colorimetric TMB Reagent (HRP Substrate, Item H)
    化学品安全说明书

  • ELISA Stop Solution (Item I)
    化学品安全说明书

  • 20X Wash Buffer (Item B)
    化学品安全说明书

pictograms

Corrosion

signalword

Warning

hcodes

Hazard Classifications

Met. Corr. 1

flash_point_f

Not applicable

flash_point_c

Not applicable

存储类别

10 - Combustible liquids

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Bingyang Lyu et al.
International journal of environmental research and public health, 16(24) (2019-12-11)
Forest therapy is a fast-growing treatment approach, as it has the potential to alleviate stressful life events and to improve psychological well-being and physical health. Bamboo forests are widespread in southwestern China. Nevertheless, a knowledge gap on the specific health
Lipika Goyal et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 25(1), 80-89 (2018-09-08)
Sorafenib is a standard first-line treatment for advanced hepatocellular carcinoma (HCC). The phase III SHARP trial showed a median time-to-progression (mTTP) of 5.5 months, overall response rate (ORR) of 2%, and median overall survival (mOS) of 10.7 months with sorafenib.
Valeria Carina et al.
Journal of applied biomaterials & functional materials, 15(3), e215-e222 (2017-05-10)
Bone tissue engineering is helpful in finding alternatives to overcome surgery limitations. Bone growth and repair are under the control of biochemical and mechanical signals; therefore, in recent years several approaches to improve bone regeneration have been evaluated. Osteo-inductive biomaterials



全球贸易项目编号

货号GTIN
RAB0731-1KT04061835165148